ETF Holdings Breakdown of PHVS

Stock Name	Pharvaris BV
Ticker	PHVS(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	NL00150005Y4

PHVS institutional holdings

The adjusted close for PHVS on 2025-12-10 was 23.68

The following institutional investment holdings of PHVS have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2025-12-10 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 1,247 USD 29,529 -1.5% 23.68

2025-12-10 IE00B3VWMM18 (iShares MSCI EMU Small Cap UCITS) 40,167 USD 817,003 -1.6% 20.34 Incorrect share price reported. Should be 23.68 not 20.34. May be due to incorrect reporting of currency . Could be EUR or USD instead IE00B3VWMM18 incorrectly reporting value of holding as USD actually is reported in EUR

Total = 41,414 USD 846,532
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2025-12-10	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	1,247	USD 29,529 -1.5%	23.68
2025-12-10	IE00B3VWMM18 (iShares MSCI EMU Small Cap UCITS)	40,167	USD 817,003 -1.6%	20.34 Incorrect share price reported. Should be 23.68 not 20.34. May be due to incorrect reporting of currency . Could be EUR or USD instead	IE00B3VWMM18 incorrectly reporting value of holding as USD actually is reported in EUR
Total =	41,414	USD 846,532

News associated with PHVS

Pharvaris N.V. (NASDAQ:PHVS) Stake Decreased by Alps Advisors Inc.: Alps Advisors Inc. lessened its holdings in shares of Pharvaris N.V. (NASDAQ:PHVS – Free Report) by 16.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 36,633 shares of the company’s stock after selling 7,038 shares during the period. Alps […] - 2025-07-15 06:25:18
Brokerages Set Pharvaris N.V. (NASDAQ:PHVS) PT at $36.20: Pharvaris N.V. (NASDAQ:PHVS – Get Free Report) has been given an average recommendation of “Buy” by the five ratings firms that are covering the company, Marketbeat reports. Five research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokers that have issued a report on the stock in the […] - 2025-07-11 04:01:06
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Stock Holdings in Pharvaris (NASDAQ:PHVS): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Pharvaris (NASDAQ:PHVS – Free Report) by 30.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 63,734 shares of the company’s stock […] - 2025-06-10 04:20:48
Pharvaris (NASDAQ:PHVS) Shares Down 5.1% Following Weak Earnings: Pharvaris (NASDAQ:PHVS – Get Free Report)’s share price traded down 5.1% during mid-day trading on Wednesday after the company announced weaker than expected quarterly earnings. The stock traded as low as $15.42 and last traded at $15.29. 6,374 shares were traded during trading, a decline of 91% from the average session volume of 73,499 shares. […] - 2025-05-16 03:00:54
Legal & General Group Plc Has $189,000 Stock Holdings in Pharvaris (NASDAQ:PHVS): Legal & General Group Plc grew its holdings in Pharvaris (NASDAQ:PHVS – Free Report) by 11.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,855 shares of the company’s stock after acquiring an additional 994 shares during the period. Legal & General Group […] - 2025-05-02 05:07:01

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.